Results 291 to 300 of about 2,285,924 (374)

Treatment of high-risk myelodysplastic syndromes. [PDF]

Haematologica
Kröger N.
europepmc   +1 more source

Recent Developments in Myelodysplastic Syndromes

, 2019
O. Fuchs
semanticscholar   +1 more source

Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High‐Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTX

American Journal of Hematology, Volume 100, Issue 11, Page 2134-2139, November 2025.
Khalil Hassan, Anmol Baranwal, Al Rabee Kassis, Jade Braun, Gabriel Bartoo, Robert Wolf, Mehrdad Hefazi, Aasiya Matin, Abhishek Mangoankar, Mithun V. Shah, Mark R. Litzow, William J. Hogan, David Dingli, Hassan B. Alkhateeb   +13 more
wiley   +1 more source

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes. [PDF]

J Clin Oncol
Zampini M, Riva E, Lanino L, Sauta E, Antunes Dos Reis R, Ejarque RMA, Maggioni G, Termanini A, Merlotti A, Campagna A, Dall'Olio L, Kulasekararaj A, Calvi M, Di Vito C, Bonometti A, Rahal D, Croci G, Boveri E, Gianelli U, Ponzoni M, Caselli R, Albertazzi S, Todisco G, Ubezio M, Crisafulli L, Frigo A, Lugli E, Mosca E, Acha P, Ghisletti S, Nicassio F, Santoro A, Diez-Campelo M, Solé F, Ades L, Platzbecker U, Santini V, Fenaux P, Haferlach T, Sallman D, Garcia-Manero G, Mavilio D, Remondini D, Castellani G, D'Amico S, Zeidan AM, Komrokji R, Kordasti S, Ficara F, Della Porta MG, CALR Consortium.   +50 more
europepmc   +1 more source

A Case of Myelodysplastic Syndrome Associated with IgA Nephropathy.

, 1999
Shintaro Hayashi, Toyohiro Okada, Hisashi Tsutsumi, T Kumakawa, Mayumi Mori   +4 more
openalex   +2 more sources

Myelodysplastic syndromes: Contemporary review and how we treat

American journal of hematology/oncology, 2016
N. Gangat, M. Patnaik, A. Tefferi
semanticscholar   +1 more source

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

Leukemia, 2016
D. Sallman, R. Komrokji, C. Vaupel, T. Cluzeau, Susan Geyer, K. McGraw, N. Ali, J. Lancet, M. Mcginniss, S. Nahas, Alexander Smith, A. Kulasekararaj, Ghulam J. Mufti, A. List, Jeff M. Hall, E. Padron   +15 more
semanticscholar   +1 more source

Plain language summary of IMerge, a Phase 3 study of imetelstat versus placebo in people with lower-risk myelodysplastic syndromes and anemia. [PDF]

Future Oncol
Komrokji RS.
europepmc   +1 more source

Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study. [PDF]

Front Pharmacol
Tian JX, Zhang P, Wang XX, Li JW, Liu DX, Liu YY, Xiao ZJ, Miao WJ.   +7 more
europepmc   +1 more source

Application of the International Prognostic Scoring System for myelodysplastic syndromes

, 1999
Brigitte Maes, Mira Meeus, Lucienne Michaux, Luc Bijnens, M. A. Boogaerts, A Hagemeijer, Chris De Wolf‐Peeters, G. Verhoef   +7 more
openalex   +1 more source